Major bank spends $250 million a year on GLP-1 drugs for its employees, CEO says

Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says

Bank of America allocates $250M yearly to GLP-1 drugs for 211,000 employees (13% of $2B healthcare budget). The scale signals enterprise confidence in preventive wellness ROI and workforce retention, reshaping benefit strategies across financial services.